‍October 21, 2025

As global rates of childhood myopia continue to rise, Akeso, a leader in precision vision technology, has introduced StellarGuard™ — a next-generation, evidence-based lens system engineered for early intervention in children and adolescents at elevated risk of developing myopia. The product represents a significant advancement in pediatric vision health, offering a preventive solution built on cutting-edge optical engineering and medical research.

The Rising Urgency of Early Myopia Prevention

Global epidemiological data show a steady increase in the prevalence and early onset of myopia among school-age children. Of particular concern is the growing number of children presenting with insufficient hyperopic reserve, a key predictor of early myopia development.

The 2025 Myopia Management White Paper formally introduced the concept of “pre-myopia”, classifying children with refractive status of ≤ +0.75D as high-risk. The report called for standardized early intervention strategies, marking a shift in clinical focus from treatment to prevention.

Medical Evidence Supports Preemptive Intervention

Longitudinal and multicenter studies now confirm that preventive action during early-stage refractive changes yields significant benefits:

• A 3-year cohort study (2023) showed that early intervention can delay myopia onset by up to 2 years.
• Clinical trials demonstrate a 40–50% reduction in myopia progression with scientifically guided lens-based strategies.
• The 2025 White Paper recommends the use of plano defocus lenses with highly aspherical microlens designs for children classified as pre-myopic.

The Dual Challenge: Indoor Correction and Outdoor Protection

In 2024, global expert consensus highlighted the protective effect of outdoor activity on myopia onset and emphasized the role of photochromic lenses in facilitating daily outdoor exposure. Photochromic functionality reduces glare, improves comfort, and supports sustained compliance with outdoor vision guidelines.

Introducing StellarGuard™: An All-in-One Preventive Lens System

Engineered from clinical insights and Akeso’s proprietary nano-lithography platform, StellarGuard™ combines high-performance defocus optics with adaptive photochromic materials to offer:

• Over 90,000 micro-defocus structures at 0.1 mm resolution for minimal distortion and maximum comfort.
• Dual-mechanism defocus delivers up to +10.00D optical signal strength for effective retinal stimulation.
• 99%+ UV protection with rapid photochromic activation and fade for enhanced outdoor visual comfort.

Tailored Solutions for Different Pediatric Needs

StellarGuard™ Active Edition
Designed for children aged 3–6 years with a family history of myopia or high visual demand. This version omits the central optical zone and applies full-retina, 6D circular defocus stimulation. The lens is fitting-free and optimized for early prevention.

StellarGuard™ Professional Edition
Intended for children aged 6–12 years with low hyperopic reserve (≤ +0.75D), early-stage myopia, or heavy near work exposure. It features a 5 mm central optical zone combined with +10.00D defocus technology for high-intensity intervention and strong inhibition of axial elongation.

Differentiators from Conventional Preventive Lenses

Market Position and Growth Outlook

With an estimated 30% of children globally exhibiting insufficient hyperopic reserve, the demand for professional-grade preventive vision products is expanding rapidly. Industry forecasts project annual growth rates exceeding 25% in this segment.

As preventive eye-care guidelines gain momentum worldwide and parents become more proactive in managing children’s visual development, StellarGuard™ stands out as a high-impact, scalable solution for early myopia control.

A Vision for the Future

“Investing in vision health is an investment in a child’s future,” said a senior Akeso spokesperson. “StellarGuard™ reflects our commitment to shifting the focus of pediatric eye care from reactive treatment to proactive prevention. By integrating science, engineering, and personalized design, we aim to protect the long-term vision of the next generation.”

About Akeso

Akeso Eyecare is a doctor-founded eye-technology company and CDMO focused on improving vision care. We design and build advanced solutions like AR displays for myopia prevention, eye tracking, extended reality devices, and digital vision health tools used in eye care and smart technology.

Our mission is to improve global vision health through smart innovation. By combining optical design, materials science, and AI, our R&D team supports partners from early research to custom design, manufacturing, and large-scale production, always guided by medical expertise, collaboration, sustainability, and patient-first thinking.

Akeso – engineering the future of vision.

www.akesoeyecare.com